LIDR-TB: large language model-integrated platform for traceable drug repurposing in tuberculosis
Tuberculosis (TB) remains a global challenge exacerbated by the ongoing emergence of drug-resistant strains. Although drug repurposing offers a cost-effective strategy to expedite therapeutic discovery, its application is impeded by the lack of unified, disease-specific frameworks that integrate fragmented chemical and...